GlassScriptPhysician profile
Bradley E Kocian
NPI 1841255809
$765.27
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $561 · 2020: $204.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $213.04 | 2019-2020 | |
| Amarin Pharma, INC. | $103.30 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $88.56 | 2019-2020 | |
| Novo Nordisk INC | $68.38 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.95 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.08 | 2019 | |
| Astellas Pharma US INC | $33.92 | 2019 | |
| Janssen Pharmaceuticals, INC | $29.03 | 2020 | |
| Abbvie INC. | $26.34 | 2020 | |
| Glaxosmithkline, LLC. | $25.91 | 2019 | |
| Pfizer INC. | $23.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $20.80 | 2019 | |
| Allergan, INC. | $14.30 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.13 | 2019 | |
| Merck Sharp & Dohme LLC | $13.00 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flowonix Medical Incorporated | $12.53 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Kocian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.